Neuroprotective potential of gliflozins
Gliflozins are a relatively new class of oral antihyperglycemic drugs that are increasingly being introduced into routine practice in the treatment of patients with type 2 diabetes mellitus (DM2). The hypoglycemic effect of gliflozins is associated with the stimulation of glucosuria, however, in add...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2023-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/13085 |